share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sachdev Amit

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sachdev Amit

福泰製藥 | 4：持股變動聲明-高管 Sachdev Amit
美股sec公告 ·  06/08 04:14
牛牛AI助理已提取核心訊息
Amit Sachdev, EVP Chief Patient & Ext Af Off at Vertex Pharmaceuticals Inc. (VRTX), completed a gift transaction of 4,600 shares of common stock on June 5, 2024. The shares were disposed of at no cost, as it was a bona fide gift. Following the transaction, Sachdev's direct holdings in the company remain at 57,290 shares. The shares disposed of were held in trust, indicating an indirect form of ownership. The transaction has been completed, and Sachdev now indirectly holds 882 shares after the event.
Amit Sachdev, EVP Chief Patient & Ext Af Off at Vertex Pharmaceuticals Inc. (VRTX), completed a gift transaction of 4,600 shares of common stock on June 5, 2024. The shares were disposed of at no cost, as it was a bona fide gift. Following the transaction, Sachdev's direct holdings in the company remain at 57,290 shares. The shares disposed of were held in trust, indicating an indirect form of ownership. The transaction has been completed, and Sachdev now indirectly holds 882 shares after the event.
2024年6月5日，Vertex Pharmaceuticals Inc.(VRTX)首席患者和企業發展官Amit Sachdev以禮物形式完成了4600股普通股的贈股交易，這些股票是免費贈予的。交易後，Sachdev在公司的直接持股仍爲57290股，而被出售的股票則由信託公司持有，表明他以間接方式擁有這些股份。交易已完成，此後Sachdev間接持有882股。
2024年6月5日，Vertex Pharmaceuticals Inc.(VRTX)首席患者和企業發展官Amit Sachdev以禮物形式完成了4600股普通股的贈股交易，這些股票是免費贈予的。交易後，Sachdev在公司的直接持股仍爲57290股，而被出售的股票則由信託公司持有，表明他以間接方式擁有這些股份。交易已完成，此後Sachdev間接持有882股。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。